AstraZeneca succeeds in treating lupus in late-stage study
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan…
by October Gallery
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan…
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid (Reuters) – U.S. drugmaker…
FILE PHOTO: A man uses a vape device in Seoul, South Korea, October 23, 2019. REUTERS/Heo Ran SEOUL (Reuters) – The South Korean Army has banned the use and possession…
WASHINGTON (Reuters) – The chairman of the U.S. House Transportation and Infrastructure Committee and the head of its aviation subcommittee said on Monday that it will continue its investigation into…
(Reuters Health) – Black women and women in rural areas are more likely to lose their jobs or face pay cuts after being diagnosed with breast cancer than white or…
WASHINGTON (Reuters) – U.S. sanctions on Iran threaten access by some Iranians to medicines that treat diseases such as cancer and epilepsy, despite exemptions in the measures for imports of…
(Reuters) – Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall…
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says…
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says…
NEW YORK (Reuters) – As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent years:…